Breast Cancer
(asked on 14th October 2024) - View Source
Question to the Department of Health and Social Care:
To ask His Majesty's Government, further to the Written Answer by Baroness Merron on 19 September (HL727), how many people are diagnosed with triple negative breast cancer in England each year.
The following table shows National Disease Registration Service (NDRS) estimates of how many people for all ages are diagnosed with triple negative breast cancer in England, and their gender, each year from 2011 to 2021:
Diagnosis year | Gender | Count |
2011 | Females | 1,098 |
2012 | Females | 1,705 |
2013 | Females | 2,353 |
2014 | Females | 2,452 |
2015 | Females | 2,464 |
2016 | Females | 2,452 |
2017 | Females | 2,531 |
2018 | Females | 2,478 |
2019 | Females | 2,325 |
2020 | Females | 1,973 |
2021 | Females | 2,224 |
2011 | Males | 3 |
2012 | Males | 3 |
2013 | Males | 0 |
2014 | Males | 5 |
2015 | Males | 2 |
2016 | Males | 7 |
2017 | Males | 1 |
2018 | Males | 3 |
2019 | Males | 5 |
2020 | Males | 2 |
2021 | Males | 2 |
A full time series will be published alongside the cancer registration statistics once the Office for National Statistics (ONS) have published the restated population estimates.
Triple negative breast cancers may be underreported as Progesterone Receptor status is an optional data item within the Cancer Outcomes and Services Data set (COSD). The Royal College of Pathologists advises that Progesterone Receptor status is not always required to be performed.